STOCK TITAN

CBD OF DENVER INC - CBDD STOCK NEWS

Welcome to our dedicated page for CBD OF DENVER news (Ticker: CBDD), a resource for investors and traders seeking the latest updates and insights on CBD OF DENVER stock.

CBD of Denver, Inc. (CBDD) is a company based in Denver, Colorado, focused on acquiring profitable assets to create value for shareholders. The company has two key subsidiaries, Luxora and Libra 9 GmbH, with diverse revenue streams. Luxora Solutions specializes in offering infrastructure solutions to cannabis clubs in Germany, providing production units and consulting services. On the other hand, Libra 9 GmbH offers innovative consumer products like the Magic Lappen and the BerlinR13 Anti-Slip solution. The recent financial results for CBD of Denver Inc. have shown significant improvements in revenue, operational efficiency, and strategic achievements, with Luxora reporting substantial growth and contributing significantly to the company's overall revenue. The company recently made the decision to unwind the acquisition of Libra 9 GmbH due to unmet revenue goals and evolving market conditions. Axel Reinke, the former CEO, has resigned, and Jan Schwager, Luxora's CEO, has taken over the role. Luxora Inc. has been experiencing remarkable growth, engaging in strategic partnerships and signing an LOI with CheckMyWeed to launch a new product called CheckMyWeed powered by NIRLAB, aiming to revolutionize cannabinoid content analysis in cannabis flowers. Additionally, Luxora is capitalizing on the upcoming changes in German cannabis laws to expand its market reach and explore new growth opportunities.

Rhea-AI Summary
CBD of Denver, Inc. (OTC Pink: CBDD) reports a strong fourth quarter with revenues reaching approximately $1,310,000. Luxora contributed approximately $1,134,000, and Libra 9 contributed approximately $176,000. The company attributes its growth to partnerships, trade shows, and new initiatives. Luxora's efforts in the European CBD wholesale market and HolistiCH GmbH's expansion are contributing to growth. The Anti-Slip division is seeing increased demand due to a novel door cut-out method and favorable regulatory changes. CBDD's management team will meet in Berlin to initiate the expansion of the Anti-Slip division, involving onboarding new installation and sales teams and beginning the rollout of Anti-Slip solutions in additional German metropolitan areas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
CBD of Denver, Inc. (CBDD) announces the launch of Luxora Real Estate AG in Switzerland, aiming to raise 10 million CHF for the acquisition of commercial real estate properties in Germany. Luxora Holding AG will retain a 51% stake, while the remaining 49% will be used to raise capital from investors. Luxora Real Estate plans to acquire commercial properties and transform them into Indoor-Farming facilities for lease to the cannabis club scene in Germany.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
CBD of Denver, Inc. (CBDD) reports robust revenue growth for Luxora, achieving approximately $320,000 in October and nearly $285,000 in November. The company signed a new agreement with a Swiss wholesale firm to provide clones of a popular CBD variety to an Austrian producer, securing up to 150 kg per month of the resulting harvest. Additionally, Luxora secured Letters of Intent with Hanf im Glück and Thank You Jane, expanding its presence in the German market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
CBD of Denver, Inc. (CBDD) partners with Channel 21 to introduce Magic Lappen teleshopping in Germany. Q3 sales reach $677,893, a significant increase from $26,907 last year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary
CBD of Denver, Inc. (OTC Pink: CBDD) announces a second listing for the Magic Lappen with EDEKA's Southwest Consortium, introducing the product to 1,130 EDEKA stores in Germany's southwest region. The company also reveals an innovative technique to transform existing bathtubs into barrier-free Anti-Slip showers, aiming to streamline installation and reduce costs. Additionally, the company expects to file its 3rd quarter financials and disclosure statement by November 20, 2023, within the extended filing period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
-
Rhea-AI Summary
Last week, Luxora, a key player in the CBD industry, gathered in Zürich, Switzerland, for a pivotal management meeting focused on expanding revenue streams. Luxora reported a strong third quarter with revenues of approximately $512,000, and expects October revenue to exceed $320,000. The company is also awaiting the finalization of new cannabis legislation in Germany and is actively developing an e-commerce site to market its 240 strains in various European countries. Luxora Solutions in Germany is anticipating the final debate on changes to the country's cannabis laws, expected to lay down the framework for initiating Cannabis Clubs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
Rhea-AI Summary
CBD of Denver, Inc. announces Q3 revenue of approximately $728,000, a significant increase from the previous year. The company attributes the growth to positive impacts of changes in German health law, particularly for its Anti-Slip product. Plans are in place to expand throughout Germany. Luxora also had its first call with investors, discussing expansion plans for the German market. The company is eagerly awaiting the final draft of the legislation on cannabis legalization in Germany.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
-
Rhea-AI Summary
CBD of Denver experiences record growth in its Anti Slip business due to improved regulatory environment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
CBD of Denver's Luxora subsidiary signs 4 Letters of Intent for production facilities in Germany to support Cannabis Clubs. Positive demand shows potential for business opportunity. Luxora aims to be a leader in the market with exclusive strains. 75,000 Euro deposit secures place. Updates to follow as legislation is finalized. Berliner Innovation repositioning and adding new products. Libra 9 expands distribution of Magic Lappen in Germany.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.22%
Tags
none
Rhea-AI Summary
CBD of Denver, Inc. announces acquisition of HOLISTICH GmbH, expanding into European market. HOLISTICH adds revenue and strong relationships with shipping companies. Luxora generates $468,000 in revenue. No immediate impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags

FAQ

What is the current stock price of CBD OF DENVER (CBDD)?

The current stock price of CBD OF DENVER (CBDD) is $0.0003 as of December 23, 2024.

What is the market cap of CBD OF DENVER (CBDD)?

The market cap of CBD OF DENVER (CBDD) is approximately 2.3M.

What is CBD of Denver, Inc. focused on?

CBD of Denver, Inc. aims to acquire profitable assets at attractive valuations to create value for its shareholders.

What are the key subsidiaries of CBD of Denver, Inc.?

The company's key subsidiaries are Luxora and Libra 9 GmbH, with Luxora focusing on providing infrastructure solutions to cannabis clubs and Libra 9 GmbH offering consumer products like Magic Lappen.

What recent achievements have been reported by CBD of Denver, Inc.?

Recent financial results for the company have shown significant improvements in revenue, operational efficiency, and strategic achievements. Luxora has been instrumental in driving revenue growth for the company.

Why did CBD of Denver, Inc. decide to unwind the acquisition of Libra 9 GmbH?

The decision to unwind the acquisition was made due to unmet revenue goals and evolving market conditions, prompting the company to reallocate resources and focus on more profitable ventures.

Who is the new CEO of CBD of Denver, Inc.?

Jan Schwager, the CEO of Luxora, has been appointed as the new CEO of CBD of Denver, Inc., following the resignation of Axel Reinke.

What strategic partnership has Luxora Inc. recently engaged in?

Luxora Inc. has signed an LOI with CheckMyWeed to launch a new product called CheckMyWeed powered by NIRLAB, revolutionizing cannabinoid content analysis in cannabis flowers.

How is Luxora Inc. leveraging the upcoming changes in German cannabis laws?

Luxora Inc. is capitalizing on the upcoming changes in German cannabis laws to expand its market reach, explore new growth opportunities, and stay ahead of the evolving regulatory landscape.

CBD OF DENVER INC

OTC:CBDD

CBDD Rankings

CBDD Stock Data

2.27M
7.55B
0%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Centennial